In terms of Regulations 30 and 33(3) of SEBI (LODR) Regulations, 2015, this is to inform that the Meeting of the Board of Directors of the Company was held today on 13th February, 2026, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 4.5 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Shreyas Intermediates approved unaudited standalone financial results for the quarter and nine months ended 31st December 2025. The company reported zero revenue from operations in Q3 FY26, compared to Rs 1,037 lakh in the previous quarter (Q2 FY26), though 9M FY26 revenue totalled Rs 1,669 lakh against nil in 9M FY25. The company posted a net loss of Rs 39 lakh for Q3 and Rs 97 lakh for 9M FY26, continuing the pattern of consistent losses (Rs 127 lakh loss in 9M FY25, Rs 159 lakh loss in full FY25). Total expenses for 9M FY26 stood at Rs 1,801 lakh, dominated by raw material costs. Basic EPS was Rs (0.05) for Q3 and Rs (0.14) for 9M FY26. Other equity stood at a negative Rs 5,846 lakh, indicating accumulated losses have eroded the company's net worth significantly.
Continued quarterly losses, zero revenue in Q3, and negative other equity of Rs 5,846 lakh against paid-up capital of Rs 7,085 lakh paint a weak picture for shareholders. The stock may remain under pressure absent a clear turnaround in operations and revenue traction.